NCT00390728View on ClinicalTrials.gov

"Insulin Glargine in Type I Diabetes Mellitus> Main Study AT.LANTUS: A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: HALT(Hypoglycaemia Avoidance With Lantus Trial)"

PHASE4CompletedINTERVENTIONAL
Enrollment

2,346

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Insulin Glargine

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00390728 - "Insulin Glargine in Type I Diabetes Mellitus> Main Study AT.LANTUS: A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: HALT(Hypoglycaemia Avoidance With Lantus Trial)" | Biotech Hunter | Biotech Hunter